Cereno ScientificCereno Scientific announces resignation of Board member at own request
Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that Johan Eriksson resigns from the Board of Directors at his own request, effective immediately.
According to Cereno Scientific’s Articles of Association, the Board of Directors shall consist of a minimum of four and a maximum of eight members. Following Johan Eriksson’s resignation, the Board will consist of five members and will therefore continue to comply with the requirements of the Articles of Association.
Bilagor & Media
0 kommentarer
Kommentera nyheten
När du kommenterar ett pressmeddelande publiceras din kommentar även i en speglad tråd under Börssnack så att alla i forumet kan delta i diskussionen!
Logga in eller skapa ett gratis konto för att kommentera nyheten!
